COST-EFFECTIVENESS OF SACRAL NEUROMODULATION VS. BOTOX FOR REFRACTORY URGENCY URINARY INCONTINENCE: RESULTS FROM THE ROSETTA TRIAL

被引:0
|
作者
Harvie, H. S. [1 ]
Amundsen, C. [2 ]
Neuwahl, S. J. [3 ]
Honeycutt, A. A. [3 ]
Rogers, R. G. [4 ]
Sung, V. W.
Lukacz, E. [5 ]
Ferrando, C. A. [6 ]
Ellington, D. [7 ]
Honeycutt, E. [3 ]
Thomas, S. M. [3 ]
Mazloomdoost, D. [8 ]
机构
[1] Univ Penn, Philadelphia, PA 19104 USA
[2] Duke, Philadelphia, PA USA
[3] RTI, Res Triangle Pk, NC USA
[4] Univ New Mexico, Albuquerque, NM 87131 USA
[5] Univ Calif San Diego, San Diego, CA USA
[6] Cleveland Clin, Cleveland, OH USA
[7] Univ Alabama Birmingham, Birmingham, AL USA
[8] NICHD, NIH, Bethesda, MD USA
基金
美国国家卫生研究院;
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
439
引用
收藏
页码:S286 / S286
页数:1
相关论文
共 50 条
  • [31] Urinary Biomarkers in Women with Refractory Urgency Urinary Incontinence Randomized to Sacral Neuromodulation versus OnabotulinumtoxinA Compared to Controls EDITORIAL COMMENT
    Kuo, Hann-Chorng
    JOURNAL OF UROLOGY, 2017, 197 (06): : 1494 - 1495
  • [32] Adherence to Oral Therapy for Urgency Urinary Incontinence: Results from the Anticholinergic Versus Botox Comparison (ABC) Trial
    Visco, Anthony G.
    Brubaker, Linda
    Jelovsek, J. Eric
    Wilson, Tracey S.
    Norton, Peggy
    Zyczynski, Halina M.
    Spino, Cathie
    Sirls, Larry
    Nguyen, John N.
    Rahn, David D.
    Meikle, Susie F.
    Nolen, Tracy L.
    FEMALE PELVIC MEDICINE AND RECONSTRUCTIVE SURGERY, 2016, 22 (01): : 24 - 28
  • [33] COMPARISON OF COST-EFFECTIVENESS OF ONABOTULINUMTOXIN A AND ANTICHOLINERGIC MEDICATIONS FOR THE TREATMENT OF URGENCY URINARY INCONTINENCE
    Zyczynski, H.
    NEUROUROLOGY AND URODYNAMICS, 2013, 32 (06) : 720 - 721
  • [34] Sacral root neuromodulation in the treatment of refractory urinary urge incontinence:: A prospective randomized clinical trial
    Weil, EHJ
    Ruiz-Cerdá, JL
    Eerdmans, PHA
    Janknegt, RA
    Bemelmans, BLH
    van Kerrebroeck, PEV
    EUROPEAN UROLOGY, 2000, 37 (02) : 161 - 171
  • [35] COST-EFFECTIVENESS OF SACRAL NEUROMODULATION IN THE TREATMENT OF IDIOPATHIC WET REFRACTORY OVERACTIVE BLADDER IN ITALY
    D'Ausilio, A.
    Bertapelle, P.
    Vottero, M.
    Del Popolo, G.
    Giannantoni, A.
    Ostardo, E.
    Spinelli, M.
    VALUE IN HEALTH, 2012, 15 (07) : A357 - A357
  • [36] Long-term cost-effectiveness analysis of sacral neuromodulation in the treatment of severe faecal incontinence
    Valencia, Mario de Miguel J.
    Hita, Juan Cabases M.
    Iriso, Eduardo Sanchez
    Martinez, Fabiola Oteiza
    Ibanez, Inaki Alberdi
    Lopez, Alfonso Alvarez
    Hurtado, Hector Ortiz
    Velasco, Mario J. de Miguel J.
    COLORECTAL DISEASE, 2023, 25 (09) : 1821 - 1831
  • [37] INTRAOPERATIVE PREDICTORS OF SACRAL NEUROMODULATION IMPLANTATION & TREATMENT RESPONSE - RESULTS FROM THE ROSETTA TRIAL
    Gill, Bradley
    Amundsen, Cindy L.
    Thomas, Sonia
    Barden, Lindsey
    Smith, Ariana
    Komesu, Yuko
    Jelovsek, J. Eric
    JOURNAL OF UROLOGY, 2020, 203 : E1020 - E1021
  • [38] COST-EFFECTIVENESS OF SACRAL NEUROMODULATION AND BOTULINUM TOXIN-A FOR PATIENTS WITH REFRACTORY IDIOPATHIC OVERACTIVE BLADDER
    Clemens, J. Quentin
    Anger, Jennifer T.
    Ganz, Michael L.
    Denevich, Svetlana
    Shah, Dhvani
    Carlson, Angeline M.
    Wittek, Michael R.
    Pashos, Chris L.
    NEUROUROLOGY AND URODYNAMICS, 2012, 31 (02) : 223 - 223
  • [39] Cost-effectiveness of sacral neuromodulation for chronic refractory constipation in children and adolescents: a Markov model analysis
    van der Wilt, A. A.
    Groenewoud, H. H. M.
    Benninga, M. A.
    Dirksen, C. D.
    Baeten, C. G. M. I.
    Bouvy, N. D.
    Melenhorst, J.
    Breukink, S. O.
    COLORECTAL DISEASE, 2017, 19 (11) : 1013 - 1023
  • [40] Characteristics Associated with Treatment Response and Satisfaction in Women Undergoing OnabotulinumtoxinA and Sacral Neuromodulation for Refractory Urgency Urinary Incontinence EDITORIAL COMMENT
    Cornu, Jean-Nicolas
    JOURNAL OF UROLOGY, 2017, 198 (04): : 896 - 896